Newstral
Article
Mmarketwatch.com on 2019-06-17 19:33
Adaptive Biotechnologies sets terms for IPO, to raise up to $212.5 million
Related news
- MCactus sets IPO terms to raise up to $407 millionmarketwatch.com
- Shares of Adaptive Biotechnologies leap after Seattle firm’s IPOSeattle Times
- MEndeavor sets IPO terms, to raise up to $619 millionmarketwatch.com
- MOneWater sets IPO terms to raise up to $63.2 millionmarketwatch.com
- MDun & Bradstreet sets IPO terms, to raise nearly $1.4 billionmarketwatch.com
- MConstruction Partners sets terms of IPO to raisemarketwatch.com
- MSmileDirectClub sets IPO terms to raise up to $1.3 billionmarketwatch.com
- MAdaptive Biotechnologies to sell more shares in IPO, as expected pricing increasesmarketwatch.com
- MKala sets terms of IPO to raise up to $96 millionmarketwatch.com
- MAdaptive Biotechnologies CEO Chad Robins on that crazy IPO and working with his older brothermarketwatch.com
- AppDynamics Sets Terms for IPOwsj.com
- MEli Lilly's Elanco sets IPO terms to raise up to $1.45 billion before optionsmarketwatch.com
- MGoosehead Insurance sets IPO terms, to raise up to $136.5 millionmarketwatch.com
- MCushman & Wakefield sets terms of IPO, to raise up to $810 millionmarketwatch.com
- MDova Pharmaceuticals sets IPO terms to raise $69.1 million before optionsmarketwatch.com
- MBlue Apron sets IPO terms to raise $510 million before optionsmarketwatch.com
- MBill.com sets IPO terms to raise up to $158.8 million, be valued at over $1.2 billionmarketwatch.com
- MKBT Financial sets IPO terms to raise up to $158 million, be valued at $500 millionmarketwatch.com
- MGritstone Oncology sets terms for IPO to raise up to $91.1 millionmarketwatch.com
- MGreenSky sets terms of IPO to raise up to $784.1 millionmarketwatch.com